| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |